GEVO Gevo, Inc.

8-K Current Report

Filed: March 16, 2026

Health Care

Industrial Organic Chemicals

Gevo, Inc. (GEVO) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Director Angelo Amorelli not standing for re-election at 2026 Annual Meeting, departing for personal reasons
• No disagreement with company on operations, policies, or practices — low-risk board transition

Other Gevo, Inc. 8-K Filings

8-K Mar 5, 2026

Get deeper insights on Gevo, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.